Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024

Rhea-AI Summary

Quest Diagnostics (DGX) will report Q4 and full year 2023 financial results on February 1, 2024. The company will hold a conference call to discuss the results and provide access to a live webcast. Participants can access the call and webcast via dial-in or online replay. The company encourages participants to read its periodic reports on file with the SEC, including risk factors and historical results.

SECAUCUS, N.J., Jan. 17, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2023 financial results on Thursday, February 1, 2024, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.   

The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call. 

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 800-934-9421 for domestic callers or 203-369-3391 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on February 1, 2024 until midnight Eastern Time on February 15, 2024.

Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
www.QuestDiagnostics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-fourth-quarter-and-full-year-2023-financial-results-on-february-1-2024-302037146.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics report Q4 and full year 2023 financial results?

Quest Diagnostics will report its Q4 and full year 2023 financial results on February 1, 2024.

How can I access the conference call and webcast?

Participants can access the conference call by dialing 888-455-0391 (U.S. and Canada) or 773-756-0467 (internationally) using the passcode: '7895081'. The live webcast will be posted on www.QuestDiagnostics.com/investor.

Where can I find the earnings release and live webcast?

The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor.

How can I access the replay of the conference call?

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 800-934-9421 (domestic) or 203-369-3391 (international); no passcode is required.

For how long will the telephone replays be available?

Telephone replays will be available from approximately 10:30 a.m. Eastern Time on February 1, 2024 until midnight Eastern Time on February 15, 2024.

What does Quest Diagnostics encourage participants to read?

The company encourages participants to read its periodic reports on file with the SEC, including risk factors and historical results of operations and financial condition.